Vaccinex, Inc.

Vaccinex, Inc.verified

VCNX

Price:

$5.4

Market Cap:

$7.69M

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical devel...[Read more]

Industry

Biotechnology

IPO Date

2018-08-09

Stock Exchange

NASDAQ

Ticker

VCNX

The PE Ratio as of May 2024 (TTM) for Vaccinex, Inc. (VCNX) is -0.21

According to Vaccinex, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.21. This represents a change of -63.46% compared to the average of -0.57 of the last 4 quarters.

Vaccinex, Inc. (VCNX) Historical PE Ratio (quarterly & annually)

How has VCNX PE Ratio performed in the past?

The mean historical PE Ratio of Vaccinex, Inc. over the last ten years is -1.85. The current -0.21 PE Ratio has changed 1.03% with respect to the historical average. Over the past ten years (40 quarters), VCNX's PE Ratio was at its highest in in the September 2023 quarter at -0.26. The PE Ratio was at its lowest in in the December 2017 quarter at -6.26.

Quarterly (TTM)
Annual

Average

-1.85

Median

-1.36

Minimum

-4.54

Maximum

-0.21

Vaccinex, Inc. (VCNX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vaccinex, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 202.54%

Maximum Annual PE Ratio = -0.21

Minimum Annual Increase = -84.63%

Minimum Annual PE Ratio = -4.54

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.21-84.63%
2022-1.397.97%
2021-1.28-3.20%
2020-1.33-32.00%
2019-1.95202.54%
2018-0.64-81.38%
2017-3.46-23.63%

Vaccinex, Inc. (VCNX) Average PE Ratio

How has VCNX PE Ratio performed in the past?

The current PE Ratio of Vaccinex, Inc. (VCNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.96

5-year avg

-1.23

10-year avg

-1.85

Vaccinex, Inc. (VCNX) PE Ratio vs. Peers

How is VCNX’s PE Ratio compared to its peers?

Vaccinex, Inc.’s PE Ratio is greater than Protara Therapeutics, Inc. (-0.75), greater than Monopar Therapeutics Inc. (-1.32), greater than Miromatrix Medical Inc. (-3.41), greater than Surrozen, Inc. (-0.58), greater than First Wave BioPharma, Inc. (-0.85), greater than Salarius Pharmaceuticals, Inc. (-0.23), greater than SAB Biotherapeutics, Inc. (-0.63), less than GeoVax Labs, Inc. (-0.15), less than ZIVO Bioscience, Inc. (0), greater than Theseus Pharmaceuticals, Inc. (-3.10), greater than Erasca, Inc. (-3.19), greater than Forte Biosciences, Inc. (-3.13), greater than Applied Molecular Transport Inc. (-0.83), less than RenovoRx, Inc. (-0.14), greater than Anebulo Pharmaceuticals, Inc. (-2.34), greater than Eledon Pharmaceuticals, Inc. (-5.87), greater than null (-2.12),

Build a custom stock screener for Vaccinex, Inc. (VCNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccinex, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaccinex, Inc. (VCNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaccinex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vaccinex, Inc.'s PE Ratio?

How is the PE Ratio calculated for Vaccinex, Inc. (VCNX)?

What is the highest PE Ratio for Vaccinex, Inc. (VCNX)?

What is the 3-year average PE Ratio for Vaccinex, Inc. (VCNX)?

What is the 5-year average PE Ratio for Vaccinex, Inc. (VCNX)?

How does the current PE Ratio for Vaccinex, Inc. (VCNX) compare to its historical average?